Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in: Archives of Gynecology and Obstetrics 5/2012

01.11.2012 | Reproductive Medicine

A panoramic view to relationships between reproductive failure and immunological factors

verfasst von: Arif Kokcu, Erhan Yavuz, Handan Celik, Devran Bildircin

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the possible roles of various immunological factors in recurrent miscarriage and unexplained infertility.

Methods

The synthesis and review of the relevant current literature in English language.

Results

Substantial evidence suggests that antiphospholipid antibodies, lupus anticoagulant, antisperm antibodies, antithyroid antibodies, anti-endometrial antibodies, antiovarian antibodies, anti-C trachomatis antibodies, cytokines, and immunological events in endometriosis and premature ovarian failure due to immunologic factors may contribute to reproductive failure including unexplained infertility and/or non-chromosomal recurrent miscarriage.

Conclusions

Elimination or suppression of the immunological factors related with reproductive failure might occupy an important place in the treatment of unexplained infertility and non-chromosomal recurrent miscarriage.
Literatur
1.
Burney RO, Schust DJ, Yao MWM (2007) Infertility. In: Berek JS (ed) Berek and Novak’s gynecology, 14th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1185–1276
2.
Kallen CB, Arici A (2003) Immune testing in fertility practice: truth or deception? Curr Opin Obstet Gynecol 15:225–231PubMedCrossRef
3.
Eskandari N, Cadieux M (2003) Infertility. In: DeCherney AH, Nathan L (eds) Current Diagnosis & Treatment Obstetrics & Gynecology, 9th edn. Lange Medical Boks/The McGraw-Hill Medical Publishing Division, New York, pp 979–990
4.
Wright KP, Johnson JV (2008) Infertility. In: Gibbs RS, Karlan BY, Haney AF, Nygaard IE (eds) Danforth’s obstetrics and gynecology, 10th edn. Lippincott Williams and Wilkins, Philadelphia, pp 705–715
5.
Sarapik A, Haller-Kikkatalo K, Utt M et al (2010) Serum anti-endometrial antibodies in infertile women—potential risk factor for implantation failure. Am J Reprod Immunol 63:349–357PubMedCrossRef
6.
Cline AM, Kutteh WH (2009) Is there a role of autoimmunity in implantation failure after in vitro fertilization? Curr Opin Obstet Gynecol 21:291–295PubMedCrossRef
7.
Ohman H, Tiitinen A, Halttunen M et al (2009) Cytokine polymorphisms and severity of tubal damage in women with Chlamydia-associated infertility. J Infect Dis 199:1353–1359PubMedCrossRef
8.
Oral E, Arici A (1997) Pathogenesis of endometriosis. Obstet Gynecol Clin North Am 24:219–233PubMedCrossRef
9.
Jasper MJ, Tremellen KP, Robertson S (2006) Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 12:301–308PubMedCrossRef
10.
Choudhury SR, Knapp LA (2001) Human reproductive failure I: immunological factors. Hum Reprod Update 7:113–134PubMedCrossRef
11.
Marshburn PB, Kutteh WH (1994) The role of antisperm antibodies in infertility. Fertil Steril 61:799–811PubMed
12.
Shibahara H, Koriyama J, Shiraishi Y et al (2009) Diagnosis and treatment of immunologically infertile women with sperm-immobilizing antibodies in their sera. J Reprod Immunol 83:139–144PubMedCrossRef
13.
Hirano Y, Shibahara H, Koriyama J et al (2011) Incidence of sperm-immobilizing antibodies in infertile women with past Chlamydia trachomatis infection. Am J Reprod Immunol 65:127–132PubMedCrossRef
14.
Chiu WW, Chamley LW (2004) Clinical associations and mechanisms of action of antisperm antibodies. Fertil Steril 82:529–535PubMedCrossRef
15.
Ulcova-Gallova Z (2010) Immunological and physicochemical properties of cervical ovulatory mucus. J Reprod Immunol 86:115–121PubMedCrossRef
16.
Aitken RJ, Parslow JM, Hargreave TB et al (1988) Influence of antisperm antibodies on human sperm function. Br J Urol 62:367–373PubMedCrossRef
17.
Kutteh WH (1999) Do antisperm antibodies bound to spermatozoa alter normal reproductive function? Hum Reprod 14:2426–2429PubMedCrossRef
18.
Bronson RA, Fleit HB, Fusi F (1990) Identification of an oolemmal IgG Fc receptor: its role in promoting binding of antibody-labelled human sperm to zona-free hamster eggs. Am J Reprod Immunol 23:87–92PubMed
19.
Coddington CC, Demochowski R, Oehninger S et al (1997) Hemizona assay: evaluation of fertility potential in patients with vasectomy reversal. Arch Androl 38:143–150PubMedCrossRef
20.
Bronson RA, Fusi F, Cooper GW et al (1990) Antisperm antibodies induce polyspermy by promoting adherence of human sperm to zona-free hamster eggs. Hum Reprod 5:690–696PubMed
21.
Rodgers AK, Wang J, Zhang Y et al (2010) Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am J Obstet Gynecol 203:494.e7–494.e14CrossRef
22.
Cooper MD, Rapp J, Jeffery-Wiseman C et al (1990) Chlamydia trachomatis infection of human fallopian tube organ cultures. J Gen Microbiol 136:1109–1115PubMedCrossRef
23.
Witkin SS (2002) Immunological aspects of genital chlamydia infections. Best Pract Res Clin Obstet Gynaecol 16:865–874PubMedCrossRef
24.
Dimitrova D, Kalaydjiev S, Hristov L, Nikolov K, Boyadjiev T, Nakov L (2004) Antichlamydial and antisperm antibodies in patients with Chlamydial infections. Am J Reprod Immunol 52:330–336PubMedCrossRef
25.
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061PubMedCrossRef
26.
Fontenot JD, Rudensky AY (2005) A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 6:331–337PubMedCrossRef
27.
Johnson PM, Christmas SE, Vince GS (1999) Immunological aspects of implantation and implantation failure. Hum Reprod 14(Suppl 2):26–36PubMedCrossRef
28.
Aoki K, Kajiura S, Matsumoto Y et al (1995) Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 345:1340–1342PubMedCrossRef
29.
Kwak JY, Beaman KD, Gilman-Sachs A et al (1995) Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 34:93–99PubMed
30.
Gajbhiye R, Suryawanshi A, Khan S et al (2008) Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online 16:817–824PubMedCrossRef
31.
Vazquez-Levin M, Kaplan P, Guzman I et al (1991) The effect of female antisperm antibodies on in vitro fertilization, early embryonic development, and pregnancy outcome. Fertil Steril 56:84–88PubMed
32.
Tian X, Zhang L, Wu Y et al (1999) Relationship between serum antisperm antibodies and anticardiolipin antibodies and clinical pregnancy outcome in an in vitro fertilization and embryo transfer program. Chin Med J (Engl) 112:34–36
33.
Horejsí J, Martínek J, Nováková D et al (2000) Autoimmune antiovarian antibodies and their impact on the success of an IVF/ET program. Ann N Y Acad Sci 900:351–356PubMedCrossRef
34.
Shatavi SV, Llanes B, Luborsky JL (2006) Association of unexplained infertility with gonadotropin and ovarian antibodies. Am J Reprod Immunol 56:286–291PubMedCrossRef
35.
Loncar D (2010) Anticardiolipin antibodies in pathogenesis of infertility. Vojnosanit Pregl 67:216–219PubMedCrossRef
36.
Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimmun [Epub ahead of print]
37.
Ata B, Tan SL, Shehata F et al (2011) A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril 95:1080–1085 e1-2.PubMedCrossRef
38.
Bianca S, Barrano B, Cutuli N et al (2009) Unexplained infertility and inherited thrombophilia. Fertil Steril 92:e4–e5PubMedCrossRef
39.
Tomassetti C, Meuleman C, Pexsters A et al (2006) Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online 13:58–64PubMedCrossRef
40.
Kim NY, Cho HJ, Kim HY et al (2011) Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures. Am J Reprod Immunol 65:78–87PubMedCrossRef
41.
Esplin MS, Branch DW, Silver R et al (1998) Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 179:1583–1586PubMedCrossRef
42.
Rushworth FH, Backos M, Rai R et al (2000) Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 5:1637–1639CrossRef
43.
Lazzarin N, Moretti C, De Felice G, Vaquero E, Manfellotto D (2012) Further evidence on the role of thyroid autoimmunity in women with recurrent miscarriage. Int J Endocrinol 2012:717185PubMed
44.
Kaprara A, Krassas GE (2008) Thyroid autoimmunity and miscarriage. Hormones (Athens) 7:294–302
45.
Sauer R, Roussev R, Jeyendran RS et al (2010) Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure. Fertil Steril 93:2441–2443PubMedCrossRef
46.
Gleicher N, Weghofer A, Oktay K et al (2009) Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging? Menopause 16:760–764PubMedCrossRef
47.
Hoek A, Schoemaker J, Drexhage HA (1997) POF and ovarian autoimmunity. Endocr Rev 18:107–134PubMedCrossRef
48.
49.
Kokcu A (2010) Premature ovarian failure from current perspective. Gynecol Endocrinol 26:555–562PubMedCrossRef
50.
Dragojević-Dikić S, Marisavljević D, Mitrović A et al (2010) An immunological insight into premature ovarian failure (POF). Autoimmun Rev 9:771–774PubMedCrossRef
51.
La Marca A, Brozzetti A, Sighinolfi G et al (2010) Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol 22:277–282PubMed
52.
Bateman BG, Nunley WC Jr, Kitchin JD III (1983) Reversal of apparent premature ovarian failure in a patient with myastenia gravis. Fertil Steril 39:108–110PubMed
53.
Edassery SL, Shatavi SV, Kunkel JP et al (2010) Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril 94:2636–2641PubMedCrossRef
54.
Cowchock FS, McCabe JL, Montgomery BB (1988) Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome). Am J Obstet Gynecol 158:118–119PubMed
55.
Blumenfeld Z, Halachmi S, Peretz BA et al (1993) Premature ovarian failure. The prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 59:750–755PubMed
56.
Corenblum B, Rowe T, Taylor PJ (1993) High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 59:988–991PubMed
57.
Gleicher N (1995) Immune dysfunction—a potential target for treatment in endometriosis. Br J Obstet Gynaecol 102(Suppl 12):4–7 Review.PubMed
58.
Vinatier D, Dufour P, Oosterlynck D (1996) Immunological aspects of endometriosis. Hum Reprod Update 2:371–384PubMedCrossRef
59.
Ozkan S, Arici A (2009) Advances in treatment options of endometriosis. Gynecol Obstet Invest 67:81–91PubMedCrossRef
60.
Iborra A, Palacio JR, Ulcova-Gallova Z, Martínez P (2000) Autoimmune response in women with endometriosis. Am J Reprod Immunol 44:236–241PubMedCrossRef
61.
Mathur SP (2000) Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 44:89–95PubMedCrossRef
62.
Siedentopf F, Tariverdian N, Rücke M et al (2008) Immune status, psychosocial distress and reduced quality of life in infertile patients with endometriosis. Am J Reprod Immunol 60:449–461PubMedCrossRef
63.
Fernandéz-Shaw S, Kennedy SH, Hicks BR, Edmonds K, Starkey PM, Barlow DH (1996) Anti-endometrial antibodies in women measured by an enzyme-linked immunosorbent assay. Hum Reprod 11:1180–1184PubMedCrossRef
64.
Olovsson M (2011) Immunological aspects of endometriosis: an update. Am J Reprod Immunol 66(Suppl 1):101–104PubMedCrossRef
65.
Inagaki J, Kondo A, Lopez LR, Shoenfeld Y, Matsuura E (2004) Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis. Clin Dev Immunol 11:261–266PubMedCrossRef
66.
Inagaki J, Hao L, Nakatsuka M et al (2011) A possible mechanism of autoimmune-mediated infertility in women with endometriosis. Am J Reprod Immunol 66:90–99PubMedCrossRef
67.
Seli E, Arici A (2003) Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med 21:135–144PubMedCrossRef
68.
Nowak NM, Fischer OM, Gust TC, Fuhrmann U, Habenicht UF, Schmidt A (2008) Intraperitoneal inflammation decreases endometriosis in a mouse model. Hum Reprod 23:2466–2474PubMedCrossRef
69.
Hassa H, Tanir HM, Tekin B, Kirilmaz SD, Sahin Mutlu F (2009) Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet 279:891–895PubMedCrossRef
70.
Tariverdian N, Theoharides TC, Siedentopf F et al (2007) Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol 29:193–210PubMedCrossRef
Metadaten
Titel
A panoramic view to relationships between reproductive failure and immunological factors
verfasst von
Arif Kokcu
Erhan Yavuz
Handan Celik
Devran Bildircin
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2480-6

Weitere Artikel der Ausgabe 5/2012

Archives of Gynecology and Obstetrics 5/2012 Zur Ausgabe

Gynecologic Oncology

A study on antioxidant and apoptotic effect of Azadirachta Indica (neem) in cases of cervical cancer

Gynecologic Oncology

Neuroendocrine tumor of the uterine cervix: a clinicopathologic study of 14 cases

Maternal-Fetal Medicine

Influence of inflammatory infiltrate and alterations of the blood flow in the etiopathogenesis of the basement membrane of the amniotic epithelium (BMAE) thickening in patients with hypertensive syndromes in pregnancy

Maternal-Fetal Medicine

The Misgav-Ladach method of cesarean section: a step forward in operative technique in obstetrics

General Gynecology

Prevalence-corrected hysterectomy rates by age and indication in Germany 2005–2006

Reproductive Medicine

Fundamental role of folliculo-luteal function in recurrent miscarriage

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise